logo

Axogen, Inc. (AXGN)



Trade AXGN now with
  Date
  Headline
1/11/2021 7:10:04 AM Axogen Sees Q4 Revenue To Be At Least $32.4 Mln; Increases Active Accounts To 893
9/30/2020 4:01:49 PM Axogen Appoints Paul Thomas To Board Of Directors
9/16/2020 10:17:41 AM Stock Alert: AxoGen Ascends 20%
7/1/2020 7:11:39 AM Axogen Estimates Preliminary Q2 Revenue To Be At Least $21 Mln, Down 21% Vs Prior Year
6/1/2020 7:14:11 AM Axogen Appoints Brad Ottinger As General Counsel And Chief Compliance Officer
2/5/2018 7:26:02 AM William Blair Starts AxoGen, Inc. (AXGN) At Outperform
11/21/2017 6:46:12 AM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.31 From -0.22
11/21/2017 6:45:49 AM Wedbush Is Increasing AxoGen, Inc. (AXGN) 2018 Rev. Estimate To 83.6 M From 83.3 M
11/2/2017 12:25:08 PM Wedbush Is Raising AxoGen, Inc. (AXGN) FY17 Estimate To -0.35 From -0.42
11/2/2017 12:24:51 PM Wedbush Is Raising AxoGen, Inc. (AXGN) Q4 17 Estimate To -0.11 From -0.14
8/3/2017 1:02:45 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.22 From -0.21
8/3/2017 1:02:31 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2017 Estimate To -0.42 From -0.41
8/3/2017 1:02:12 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) Q3 17 Estimate To -0.10 From -0.09
5/19/2017 7:03:16 AM Wedbush Reiterates AxoGen, Inc. (AXGN) At Outperform With $17 Up From $14 Price Target
2/23/2017 6:42:57 AM Wedbush Is Raising AxoGen, Inc. (AXGN) 2017 Rev. Estimate To 57.9 M From 57.11 M
2/23/2017 6:41:57 AM Wedbush Reiterates AxoGen, Inc. (AXGN) At Outperform With $12 Price Target
1/10/2017 9:14:21 AM Wedbush Reiterates AxoGen, Inc. (AXGN) At Outperform With $12 Price Target
11/22/2016 6:35:48 AM Wedbush Reiterates AxoGen, Inc. (AXGN) At Outperform With $12 Price Target
11/7/2016 6:12:16 AM Wedbush Is Lowering AxoGen, Inc. (AXGN) 2017 Rev. Estimate To 57.11 M From 57.513 M